scholarly journals Stability Over Time Of High Incidence Bladder Cancer In An Industrialized Area In North-Eastern Spain. A Longitudinal Study In A Region Of 400,000 Inhabitants.

2021 ◽  
Author(s):  
José María Caballero ◽  
Meritxell Perez-Marquez ◽  
Jose M. Gili ◽  
Juan Camilo Pereira ◽  
Alba Gomáriz ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Registries ◽  
Incidence Rates ◽  
Standard Population ◽  
European Standard Population ◽  
North Eastern ◽  
The World ◽  
World Standard ◽  
Primary Bladder ◽  
Number Of Individuals

Abstract Purpose: To study whether the incidence of bladder cancer in an industrialized area in ​​North-Eastern Spain remains as high as in the nineties.Methods: Patients diagnosed with histologically confirmed primary bladder cancer, during 2018-2019, in an area in North-Eastern Spain (430,883 inhabitants) were included. Crude incidence rates were estimated per 100,000 person-year based on the number of individuals getting their first diagnosis. Direct age-standardized incidence rates were calculated applying both the European and the World Standard Populations.Results: 295 patients were included (mean age 72.5±10.3 years; 89.8% men). The crude rate was 62.6 (95%CI:55.0-70.1) for men and 6.8 (95%CI:4.4-9.3) for women. The annual rate adjusted to the European Standard Population was 85.3 (95%CI:75.0-95.5) for men and 7.0 (95%CI:4.5-9.5) for women, and adjusted to the World Standard Population, 31.7 (95%CI:27.9-35.5) and 2.9 (95%CI:1.8-3.9) respectively. Conclusion: The incidence of bladder cancer in this area in ​​North-Eastern Spain is one of the highest in men and one of the lowest in women, both in Europe and Worldwide. The decrease in the industrial activity has not led to a decrease in bladder cancer incidence. The heterogeneity of bladder cancer registries in terms of definition and inclusion criteria makes it difficult to compare results.

Incidence and trends of pancreatic cancer (PC) in Girona: A population-based study from the Girona Cancer Registry (1994-2015).

2019 ◽  
Vol 37 (4_suppl) ◽  
pp. 225-225
Author(s):  
Adelaida Garcia-Velasco ◽  
Carmen Carmona ◽  
Antonia Bianca ◽  
Helena Teixidor ◽  
Marc Valero ◽  
...  
Keyword(s):  
Cancer Registry ◽  
The Elderly ◽  
Population Based ◽  
Incidence Rates ◽  
Neuroendocrine Neoplasms ◽  
Standard Population ◽  
European Standard Population ◽  
Drastic Increase ◽  
Adjusted Incidence ◽  
Incident Cases

225 Background: PC is the third leading-cause of cancer death in Spain. In this study we aim to investigate PC’s incidence and trends during 1994-2015 in Girona. Methods: Data were extracted from the population-based Girona Cancer Registry. Incident PC cases were classified using the ICD-O-3 Third Edition. Age-adjusted incidence rates (ASRE) to the European standard population and world standard population (ASRW) were obtained. Trends were assessed using the estimated annual percentage of change (EAPC) of the ASRE13. Results: We identified 1590 PC incident cases, 45.8% females and 54.2%. Patients > 64 years old represented a 72.6% of cases. According to histology, epithelial tumors stand for a 44% of cases and neuroendocrine neoplasms represented only the 3% of all cases, being most of PC tumors’ histology non-specified. Cases detected only by death certificates (DCO) were 7.7% in males and 7.4% in females. For the whole study population, crude rate (CR) cancer incidence was 11.26 cases per 100,000 inhabitants/year (12.17 men; 10.34 women). Regarding the ASR, results show an ASRE13 of 12.99 (95% CI 12.36;13.65) and ASRW of 5.58 (95% CI 5.8;13.655.91). Age-specific rates reflected a drastic increase with age, having the population over 85 years the highest rate (74.5 cases per 100,000 inhabitants/year). We also found a significant increase in incidence of PC cases over the study period, with an EAPC of 1.41% per year, present in both men (EAPC = 1.30%) and women (EAPC = 1.37%). Conclusions: Incidence rates of PC in Girona are within the European average, and likewise they have been increasing for the last two decades. There is an increase of incidence in the elderly population reflected in age-specific rates, reason whereby we believe there are a high proportion of unspecific histologies. These results can be used as baseline for further research.

scholarly journals Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years

2020 ◽  
Vol 17 (24) ◽  
pp. 9538
Author(s):  
Adelaida García-Velasco ◽  
Lluís Zacarías-Pons ◽  
Helena Teixidor ◽  
Marc Valeros ◽  
Raquel Liñan ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
International Classification Of Diseases ◽  
Population Based ◽  
Incidence Rates ◽  
Future Research ◽  
Kaplan Meier ◽  
Standard Population ◽  
European Standard Population ◽  
Classification Of Diseases ◽  
Incident Cases

(1) Background: We investigated the incidence and survival trends for pancreatic cancer (PC) over the last 25 years in the Girona region, Catalonia, Spain; (2) Methods: Data were extracted from the population-based Girona Cancer Registry. Incident PC cases during 1994–2015 were classified using the International Classification of Diseases for Oncology Third Edition (ICD-O-3). Incidence rates age-adjusted to the European standard population (ASRE) and world standard population (ASRW) were obtained. Trends were assessed using the estimated annual percentage of change (EAPC) of the ASRE13. Observed and relative survivals (RS) were estimated with the Kaplan–Meier and Pohar Perme methods, respectively; (3) Results: We identified 1602 PC incident cases. According to histology, 44.4% of cases were exocrine PC, 4.1% neuroendocrine, and 51.1% malignant-non-specified. The crude incidence rate (CR) for PC was 11.43 cases-per-100,000 inhabitants/year. A significant increase of incidence with age and over the study period was observed. PC overall 5-year RS was 7.05% (95% confidence interval (CI) 5.63; 8.84). Longer overall survival was observed in patients with neuroendocrine tumours (5-year RS 61.45%; 95% CI 47.47; 79.55). Trends in 5-year RS for the whole cohort rose from 3.27% (95% CI 1.69–6.35) in 1994–1998 to 13.1% (95% CI 9.98; 17.2) in 2010–2015; (4) Conclusions: Incidence rates of PC in Girona have increased in the last two decades. There is a moderate but encouraging increase in survival thorough the study period. These results can be used as baseline for future research.

Urological malignancy incidence rates over time by county rurality.

2020 ◽  
Vol 38 (6_suppl) ◽  
pp. 750-750
Author(s):  
Adam John Gadzinski ◽  
John L. Gore ◽  
Anobel Y. Odisho ◽  
Sima P. Porten ◽  
Peter Carroll ◽  
...  
Keyword(s):  
Rural Areas ◽  
Cancer Registries ◽  
Incidence Rates ◽  
Official Position ◽  
Metro Area ◽  
Rural Counties ◽  
Standard Population ◽  
Using Data ◽  
Adjusted Incidence ◽  
Over Time

750 Background: Approximately 20% of the U.S. population resides in non-metropolitan (rural) areas. We aimed to evaluate urological cancer incidence among populations residing in metropolitan (metro) and rural counties, categorized by adjacency to a metro area. Methods: Using data from CDC’s National Program of Cancer Registries and NCI’s Surveillance, Epidemiology, and End Results Program, we compared incidence rates of prostate (PCa), kidney (KCa), and bladder (BCa) cancers diagnosed during 2007–2011 and 2012–2016 among adults age ≥ 20 years residing in metro and rural counties, as designated by rural-urban continuum codes. Rural counties were divided into those adjacent to a metro area (Rural-A) and those not adjacent to a metro area (Rural-NA). For the time period studied, these data cover approximately 97% of the US population. Rates were age-adjusted to the 2000 U.S. standard population. Results: We identified 1,980,168 PCa, 541,225 KCa, and 688,562 BCa cases newly diagnosed during 2007–2016. Patients from rural-A counties comprised 11% of all cases, rural-NA counties 6%, and metro counties 83%. Table shows the age-adjusted incidence per 100,000 with 95% confidence intervals. Overall, PCa and BCa incidence decreased over time; KCa incidence increased. PCa exhibited higher incidence rates in metro areas; KCa and BCa had higher incidence rates in rural counties (Table). Conclusions: Rural counties have higher BCa and KCa incidence relative to metro counties, but lower PCa incidence. Changes in PCa screening practices may have contributed to decreases in PCa incidence. Further investigation is needed to understand how rurality influences KCa and BCa epidemiology. Disclaimer: The findings and conclusion of this report are those of the authors and do not represent the official position of the CDC.[Table: see text]

Population-based incidence of gastrointestinal stromal tumors in Puglia

2020 ◽  
pp. 030089162093194
Author(s):  
Francesco Cuccaro ◽  
Maria Giovanna Burgio Lo Monaco ◽  
Ivan Rashid ◽  
Lucia Bisceglia ◽  
Enrico Caputo ◽  
...  
Keyword(s):  
Incidence Rate ◽  
Gastrointestinal Stromal Tumors ◽  
Age Groups ◽  
Cancer Registries ◽  
Incidence Rates ◽  
International Studies ◽  
Crude Incidence Rate ◽  
Crude Incidence ◽  
Stromal Tumors ◽  
European Standard Population

Introduction: This study presents the incidence of gastrointestinal stromal tumors (GISTs) in an Italian region of over 4 million inhabitants monitored for 10 years and is the largest incidence study of this type of cancer conducted so far in Italy. Methods: In order to ensure the registration of all GISTs, including those with nonmalignant behavior, a cancer list was integrated with the cases found through an ad hoc data mining process that covered all the pathologic reports of Puglia. Case distributions by sex, age groups, site, and prognostic groups according to Miettinem and Lasota classification and crude and age-standardized incidence rates were produced. Results: In the 10-year period 2006 to 2015, 708 cases of GIST were recorded in Puglia. The average crude incidence rate was 1.7 per 100,000 person-years and the age-standardized incidence rate, using 2013 European standard population, was 1.8 per 100,000 person-years (95% confidence interval [CI], 1.6–1.9). Incidence was higher in men than in women: crude incidence rate was 2.0 per 100,000 person-years and age-standardized incidence rate 2.2 per 100,000 person-years (95% CI, 2.0–2.4) in men and 1.5 per 100,000 person-years and 1.4 per 100,000 person-years (95% CI, 1.2–1.6) in women. Discussion: Our incidence rates are comparable with those of other international studies and they are located in the medium to high end of the range. The comparisons are affected by a different capacity of the cancer registries to intercept and record GISTs with nonmalignant behavior. Distribution of cases for sex, age groups, sites, and prognostic risk groups are consistent with previous results.

scholarly journals Trends of HIV Mortality between 2001 and 2018: An Observational Analysis

2021 ◽  
Vol 6 (4) ◽  
pp. 173
Author(s):  
Chinmay Jani ◽  
Kripa Patel ◽  
Alexander Walker ◽  
Harpreet Singh ◽  
Omar Al Omari ◽  
...  
Keyword(s):  
South Africa ◽  
World Health ◽  
Mortality Data ◽  
Observational Analysis ◽  
Standard Population ◽  
Hiv Mortality ◽  
The World ◽  
World Standard ◽  
Males And Females ◽  
Health Organization

Since the beginning of the epidemic in the early 1980s, HIV-related illnesses have led to the deaths of over 32.7 million individuals. The objective of this study was to describe current mortality rates for HIV through an observational analysis of HIV mortality data from 2001 to 2018 from the World Health Organization (WHO) Mortality Database. We computed age-standardized death rates (ASDRs) per 100,000 people using the World Standard Population. We plotted trends using locally weighted scatterplot smoothing (LOWESS). Data for females were available for 42 countries. In total, 31/48 (64.60%) and 25/42 (59.52%) countries showed decreases in mortality in males and females, respectively. South Africa had the highest ASDRs for both males (467.7/100,000) and females (391.1/100,000). The lowest mortalities were noted in Egypt for males (0.2/100,000) and in Japan for females (0.01/100,000). Kyrgyzstan had the greatest increase in mortality for males (+6998.6%). Estonia had the greatest increase in mortality for females (+5877.56%). The disparity between Egypt (the lowest) and South Africa (the highest) was 3042-fold for males. Between Japan and South Africa, the disparity was 43,454-fold for females. Although there was a decrease in mortality attributed to HIV among most of the countries studied, a rising trend remained in a number of developing countries.

Examining the Kinships System of the Bodo

Think India ◽  
2019 ◽  
Vol 22 (3) ◽  
pp. 186-192
Author(s):  
Dr. Oinam Ranjit Singh ◽  
Dr. Nushar Bargayary
Keyword(s):  
Social Relationships ◽  
Social Cohesion ◽  
Social Relationship ◽  
Vital Role ◽  
Eastern Region ◽  
The North ◽  
Kinship System ◽  
North Eastern ◽  
The World ◽  
The Relationship

The Bodo of the North Eastern region of India have their own kinship system to maintain social relationship since ancient periods. Kinship is the expression of social relationship. Kinship may be defined as connection or relationships between persons based on marriage or blood. In each and every society of the world, social relationship is considered to be the more important than the biological bond. The relationship is not socially recognized, it fall outside the realm of kinship. Since kinship is considered as universal, it plays a vital role in the socialization of individuals and the maintenance of social cohesion of the group. Thus, kinship is considered to be the study of the sum total of these relations. The kinship of the Bodo is bilateral. The kin related through the father is known as Bahagi in Bodo whereas the kin to the mother is called Kurma. The nature of social relationships, the kinship terms, kinship behaviours and prescriptive and proscriptive rules are the important themes of the present study.

On Drummondia sinensis var. ussuriensis (Drummondiaceae, Bryophyta)

2012 ◽  
Vol 46 ◽  
pp. 235-244 ◽  
Author(s):  
O. M. Afonina ◽  
V. Ya. Cherdantseva
Keyword(s):  
Far East ◽  
Biosphere Reserve ◽  
Southern Siberia ◽  
The Far East ◽  
North Eastern ◽  
The World ◽  
World Distribution ◽  
North Eastern Part ◽  
State Nature

Drummondia sinensis Mull. Hal. var. ussuriensis (Broth.) Vitt has been found in Sokhondinskiy State Nature Biosphere Reserve (Zabaikalsky Territory, Southern Siberia). Earlier it was known in Russia from the southern part of the Far East as well as in north-eastern part of China and North of Mongolia. The type variety of Drummondia sinensis occurs in eastern part of China, Japan and India. Description and illustration of D. sinensis var. ussuriensis based on the material collected in Russia are given, comparison with close taxa is provided, and the world distribution is dicussed.

Westward Palaearctic range expansion of Papilio demoleus Linnaeus, 1758 (Lepidoptera: Papilionidae) and its arrival at Mediterranean coastal regions of Turkey and Syria

2020 ◽  
Vol 71 (4) ◽  
pp. 257-272
Author(s):  
Onat Başbay ◽  
Mudar Salimeh ◽  
Eddie John
Keyword(s):  
Eastern Mediterranean ◽  
Economic Importance ◽  
Invasive Pest ◽  
Pest Species ◽  
Coastal Regions ◽  
The North ◽  
North Eastern ◽  
The World ◽  
Invasive Pest Species ◽  
Papilio Demoleus

We review the continuing and extensive spread of Papilio demoleus in south-eastern Turkey and in regions of Turkey and Syria adjacent to the north-eastern Mediterranean. Since the authors documented the arrival of this attractive but potentially destructive papilionid species at coastal areas of Syria in 2019, regular monitoring has confirmed successful overwintering there, as well as in Turkey. As previously indicated, P. demoleus is widely recognized as an invasive pest species in Citrus-growing areas of the world and hence its arrival is of potential economic importance to a region in which citrus is widely grown.

scholarly journals Development and design of the Hantavirus registry - HantaReg - for epidemiological studies, outbreaks and clinical studies on hantavirus disease

2021 ◽  
Author(s):  
Felix C Koehler ◽  
Linda Blomberg ◽  
Thomas Theo Brehm ◽  
Stefan Büttner ◽  
Oliver A Cornely ◽  
...  
Keyword(s):  
Data Entry ◽  
Scoring Systems ◽  
Epidemiological Studies ◽  
Incidence Rates ◽  
Case Report Form ◽  
Treatment Pathways ◽  
General Data Protection Regulation ◽  
The World ◽  
Electronic Case Report Form ◽  
Substantial Risk

Abstract Background Frequent outbreaks around the globe and endemic appearance in different parts of the world emphasize the substantial risk of hantavirus diseases. Increasing incidence rates, trends of changing distribution of hantavirus species and new insights into clinical courses of hantavirus diseases call for multinational surveillance. Furthermore, evidence-based guidelines for the management of hantavirus diseases and scoring systems, which allow stratification of patients into risk categories, are lacking. Methods Hantavirus registry (HantaReg) is a novel registry platform facilitating multinational research of hantavirus-caused diseases, such as haemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). HantaReg provides an electronic case report form and uses the General Data Protection Regulation compliant platform clinicalsurveys.net, which can be accessed from any internet browser in the world. Having a modular structure, the registry platform is designed to display or hide questions and items according to the documented case (e.g. patient with HFRS versus HCPS) to facilitate fast, but standardized, data entry. Information categories documented in HantaReg are demographics, pre-existing diseases, clinical presentation, diagnostic and therapeutic approaches, as well as outcome. Conclusions HantaReg is a novel, ready-to-use platform for clinical and epidemiological studies on hantavirus diseases and facilitates the documentation of the disease course associated with hantavirus infections. HantaReg is expected to promote international collaboration and contributes to improving patient care through the analysis of diagnostic and treatment pathways for hantavirus diseases, providing evidence for robust treatment recommendations. Moreover, HantaReg enables the development of prognosis-indicating scoring systems for patients with hantavirus disease.

Sign in / Sign up

Export Citation Format

Share Document